Log in or Sign up for Free to view tailored content for your specialty!
Polymyositis News
Few randomized clinical trials support corticotropin injection for most indications
Few randomized clinical trials support using repository corticotropin injection for most FDA-approved indications, including rheumatoid arthritis, ankylosing spondylitis, lupus, optic neuritis and nephrotic syndrome, according to researchers.
Dermatomyositis incidence, prevalence higher than previously reported
Using the most recent EULAR/American College of Rheumatology criteria, researchers at the Mayo Clinic and the Karolinska Institute determined that the incidence and prevalence of dermatomyositis are higher than previously reported.
Log in or Sign up for Free to view tailored content for your specialty!
DMARD interruptions in rheumatic disease persist despite reduced COVID-related anxiety
Despite a significant decrease in anxiety related to COVID-19, patients with autoimmune rheumatic disease continue to experience frequent interruptions in their medication use, according to survey data presented at ACR Convergence 2021.
Breakthrough COVID-19 infection risk highest in RA, gout, polydermatomyositis, vasculitis
Patients with rheumatoid arthritis, gout, polydermatomyositis, vasculitis and those with multiple rheumatic diseases were at greatest risk for breakthrough COVID-19 infection, despite full or partial vaccination vs. those without rheumatic disease.
Systemic autoimmune disease does not affect overall survival in lung transplant
Data presented at ACR Convergence 2021 support the use of life-saving lung transplantation among qualified patients with systemic autoimmune diseases.
‘Pearls and myths’: Oral, cutaneous signs of rheumatic disease hold ‘clue’ to intervention
Managing oral, ocular and cutaneous complications is critical to optimizing outcomes in conditions ranging from Sjögren’s syndrome to juvenile dermatomyositis, according to a presenter who offered a cross-section of “pearls and myths” at ACR Convergence 2021.
Vitamin D, omega-3 supplements reduced risk for incident autoimmune disease
The use of vitamin D3 or omega-3 fatty acid supplements over a 5-year period may reduce the incidence of autoimmune disease in older adults by 25% to 30%, according to data presented at ACR Convergence 2021.
FDA approves Cortrophin Gel for rheumatoid arthritis, multiple sclerosis
The FDA has approved a supplemental new drug application for ANI Pharmaceutical’s Cortrophin Gel to treat rheumatoid arthritis, multiple sclerosis and certain other autoimmune diseases, according to a company press release.
Healio launches rheumatology quiz platform, Rheum + Boards
Healio announced the launch of Rheum and Boards, a quiz-based, online learning resource for rheumatologists, according to a Healio press release.
Dermatomyositis incidence, prevalence higher than previously reported
Using the most recent EULAR/American College of Rheumatology criteria, researchers at the Mayo Clinic and the Karolinska Institute determined that the incidence and prevalence of dermatomyositis are higher than previously reported.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read